חזרה לתוצאות החיפוש

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

מצבים רפואיים

Advanced Solid Tumor · Unresectable Solid Tumor · Metastatic Solid Tumor · Colorectal Adenocarcinoma · Pancreatic Adenocarcinoma · Lung Cancer · Ovarian Cancer · Breast Cancer · Head and Neck Squamous Cell Carcinoma · Prostate Cancer · Bladder Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • HonorHealth Research Institute, Scottsdale, Arizona, United States

    Study coordinator · 833-354-6667

  • The University of Arizona Cancer Center, Tucson, Arizona, United States

    Study coordinator · UACC-ClinicalTrialsInfo@arizona.edu

  • USC - Norris Comprehensive Cancer Center, Los Angeles, California, United States

    Study coordinator · clinical.trials@med.usc.edu · 323-865-0451

  • University of California Davis Comprehensive Cancer Center, Sacramento, California, United States

    Study coordinator · 916-703-5558

  • University of California San Francisco, San Francisco, California, United States

    Study coordinator · hdfccc.cip@ucsf.edu

  • University of Miami - Sylvester Comprehensive Cancer Center, Miami, Florida, United States

    Study coordinator · 407-765-9589

  • The University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

    Study coordinator · 855-403-0533

  • University of Kentucky Markey Cancer Center, Lexington, Kentucky, United States

    Study coordinator · 859-257-4488

  • Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States

    Study coordinator · 410-955-8964

  • Hackensack University Medical Center, Hackensack, New Jersey, United States

    Contact: Study coordinator (Oncology Clinical Research Referral Office) · OncologyResearchReferral@hmhn.org · 551-996-1777

  • NYU Langone Health, New York, New York, United States

    Study coordinator · 212-263-4432

  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Study coordinator · 646-608-4042

  • Duke Cancer Institute, Durham, North Carolina, United States

    Study coordinator · 866-385-3123

  • Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Aliya Rogers) · axr028@jefferson.edu

  • Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

    Study coordinator · 215-214-1515

  • Sarah Cannon Research Institute (SCRI) Oncology Partners, Nashville, Tennessee, United States

    Study coordinator · 615-329-7640

  • Vanderbilt University Medical Center, Nashville, Tennessee, United States

    Study coordinator · 615-936-8422

  • Mary Crowley Cancer Research, Dallas, Texas, United States

    Study coordinator · 972-566-3000

  • Baylor University Medical Center, Dallas, Texas, United States

    Study coordinator · 888-507-3732

  • MD Anderson Cancer Center, Houston, Texas, United States

    Study coordinator · 888-989-5374

  • Fred Hutchinson Cancer Center, Seattle, Washington, United States

    Study coordinator · 855-557-0555
צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)